HeartSciences (HSCS) Gross Profit (2021 - 2025)

HeartSciences has reported Gross Profit for 5 years, with the latest figure at $1411.0 in Q4 2025.

• For the quarter ending Q4 2025, Gross Profit changed N/A year-over-year to $1411.0; the trailing twelve-month figure through Jan 2026 stood at $5021.0 (down 59.89% YoY), and the FY2025 full-year result was $2470.0, down 80.27% from the prior year.
• Gross Profit for Q4 2025 stood at $1411.0, up from $1140.0 in the prior quarter.
• The five-year high for Gross Profit was $10139.0 in Q1 2024, with the low at $1140.0 in Q3 2025.
• Historically, Gross Profit has averaged $2637.7 across 5 years, with a median of $1807.0 in 2021.
• Annual changes were most pronounced in 2023 — Gross Profit sank 36.9% — and 2024, when it soared 752.02%.
• HeartSciences' Gross Profit stood at $1728.0 in 2021, then slumped by 32.64% to $1164.0 in 2022, then jumped by 104.47% to $2380.0 in 2023, then jumped by 326.01% to $10139.0 in 2024, then tumbled by 86.08% to $1411.0 in 2025.
• The last three Gross Profit figures came in at $1411.0 (Q4 2025), $1140.0 (Q3 2025), and $2470.0 (Q2 2025), per Business Quant data.